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The major renal Naþ /phosphate cotransporter, NaPi-IIa, is
regulated by a number of factors including parathyroid
hormone (PTH), dopamine, and dietary phosphate intake.
PTH induces the acute internalization of NaPi-IIa from the
brush border membrane (BBM) and its routing to and
subsequent degradation in lysosomes. Previous work
indicated that megalin, part of the apical receptor-mediated
endocytic apparatus, may play a role in the PTH-induced
removal of NaPi-IIa. Here we examined in rats the
time-dependent internalization route of NaPi-IIa after acute
PTH application using immunohistochemistry and markers of
several endocytic compartments. NaPi-IIa removal from the
BBM was detectable as early as 5 min after PTH injection.
After 10–15 min, NaPi-IIa was localized in subapical
compartments positive for clathrin. Shortly thereafter,
NaPi-IIa appeared in endosomes stained for EEA1 (early
endosomal antigen 1). After 45–60 min, NaPi-IIa was found in
late endosomes/lysosomes marked with lgp120. In contrast,
no change in the subcellular localization of megalin and the
Naþ /Hþ exchanger NHE3 was detected up to 60 min after
PTH injection. To further characterize the internalization
route, insulin, as a marker for receptor-mediated endocytosis,
and horseradish peroxidase (HRP) and fluorescein
isothiocyanate (FITC)-dextran (10 kDa), as markers for
fluid-phase mediated endocytosis, were used. NaPi-IIa
colocalized with insulin 5–30 min after PTH injection but
did not overlap with HRP or FITC-dextran. These results
demonstrate a distinct internalization route of NaPi-IIa in
response to acute PTH application that may involve
the receptor-mediated endocytic pathway including
clathrin-coated vesicles and EEA1-positive early endosomes,
and routes NaPi-IIa to lysosomes for degradation.
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Inorganic phosphate (Pi) homeostasis is effectively balanced
between intestinal absorption via the Naþ /phosphate
cotransporter NaPi-IIb and the renal excretion regulated at
the level of the apical Naþ /phosphate cotransporters NaPi-
IIa and NaPi-IIc.1 Transport of Pi across the proximal tubular
apical membrane is mainly performed by NaPi-IIa.2,3 A
variety of stimuli regulate the abundance of NaPi-IIa and
activity of Na/Pi cotransport including dietary phosphate
intake, acid–base homeostasis, and a number of hormones
such as parathyroid hormone (PTH), dopamine, and steroid
hormones.1,3,4 Rapid up- or downregulation of the trans-
porter subsequent to acute changes in phosphate intake or
PTH levels is based rather on post-transcriptional events,
including intracellular trafficking, than on transcriptionally
regulated changes in the mRNA levels of NaPi-IIa.1,3,5 A
decrease of proximal tubular reabsorption of phosphate (Pi),
which can be provoked by PTH, has been shown to correlate
with a decrease in the number of type IIa Na/Pi cotran-
sporters residing in the brush border membrane (BBM).2
Internalization of NaPi-IIa in vivo most likely occurs at the
invaginated membrane regions at the base of the BBM as
demonstrated in PTH-treated rats.6 Internalized NaPi-IIa
proteins are subsequently directed to the lysosomes for
degradation.6–8 Similar observations were made in studies
with OK cells, a cell line with some proximal tubular
characteristics.7,9
In a first step of its rapid downregulation by PTH,
NaPi-IIa accumulates transiently in the apical endocytic
compartment of the proximal tubule before being degraded
in a second step in the lysosomes within the course of one to
several hours.7,8,10 Similarities of this process with receptor-
mediated endocytosis of ligands have been highlighted.10–13
Previously, we have investigated NaPi-IIa internalization
using immunohistochemical methods and found evidence
for a distinct internalization route.6 Moreover, we have
recently demonstrated in two mouse models that loss of the
endocytic receptor megalin itself or its chaperone protein
RAP leads to an impairment and delay of the PTH-induced
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NaPi-IIa internalization.14,15 Taken together, these data point
to a possible involvement of the receptor-mediated endo-
cytic pathway in the internalization of NaPi-IIa in response
to PTH.
However, little is known about the route of internalization
and the underlying mechanisms of the rapid PTH-dependent
removal of NaPi-IIa molecules and their subsequent
intracellular routing to lysosomes. Therefore, the present
study aimed to determine the route of retraction of NaPi-IIa
in vivo after PTH treatment, employing confocal microscopy
and dual labeling with markers of specific compartments
such as clathrin-coated pits and endosomes together with
markers for receptor-mediated and fluid-phase endocytosis.
We used insulin as a representative marker for receptor-
mediated endocytosis. Upon insulin binding, activated
insulin receptors complexed with insulin are released from
microvilli, segregate in clathrin-coated pits, and enter the
cells. In endosomes, insulin is uncoupled from its receptor
and the receptor recycles back to the cell surface, whereas
insulin molecules are targeted to late endosomes and
lysosomes where they are degraded.16 Horseradish peroxidase
(HRP) was used as a marker of fluid-phase endocytosis.13
The results indicate that the retraced NaPi-IIa molecules
are following the pathway of receptor-mediated endocytosis
being routed via clathrin-coated vesicles to early endosomes
and lysosomes.
RESULTS
A low-Pi diet increases the expression of NaPi-IIa cotran-
sporters predominantly in the brush border of superficial
nephrons, the sites that under normal dietary conditions
display a more moderate expression of the cotransporter.14,17
Therefore, all animal experiments were performed on rats fed
a low-Pi diet for 3 days, in order to obtain maximal NaPi-IIa
expression in all nephron generations as the starting point.
Effect of PTH treatment on NaPi-IIa distribution
The method of injecting PTH into the vena cava in
anesthetized rats allowed us to perform the hormone
treatment for periods as short as 5 min and, without
noticeable side effects from anesthesia, as long as 60 min.
The initial immunohistochemical evaluation of the PTH
effect at various time points (i.e. 5, 15, 30, and 60 min after
injection) showed that the onset of NaPi-IIa internalization
from the BBM was already detectable after 5 min and was
very pronounced after 15 min. With prolonged treatment (30
and 60 min), the expression of NaPi-IIa cotransporters
decreased in superficial as well as in juxtamedullary nephrons
(Figure 1). NaPi-IIa in control animals showed almost
exclusively BBM localization (the BBM was stained against
actin in red, NaPi-IIa in green, overlay of NaPi-IIa and actin
appeared in bright yellow). Higher magnifications of cross-
sections of proximal tubules in PTH-injected rats illustrate
that the intensity of the NaPi-IIa cotransporter staining
(green label) was decreased in the BBM with prolonged PTH
treatment (Figure 2). In PTH-injected animals, NaPi-IIa-
Control PTH 5 min
PTH 30 min PTH 60 min
PTH 15 min
Figure 1 | Type IIa NaPi cotransporter (NaPi-IIa) protein in the
kidney cortex of control rats and of rats 5, 15, 30, or 60 min after
injection with 1-34 PTH; cryostat sections, immunofluorescence.
NaPi-IIa labeling was strongly reduced in kidneys immediately 5 min
after PTH application. After prolonged periods after PTH injection
(15 and 30 min), NaPi-IIa staining remained strongest in proximal
convoluted tubules of juxtamedullary nephrons, which almost
completely disappeared 60 min after PTH administration.
Bar¼B200 mm.
Control PTH 5 min PTH 15 min
PTH 30 min PTH 60 min
Figure 2 | S1 segments of superficial nephrons stained with an
antibody against NaPi-IIa (green label) and with rhodamine-
phalloidin against b-actin filaments (red); cryostat sections,
immunofluorescence. Under control conditions, a high degree of
overlap (yellow appearance) between NaPi-IIa and actin is seen,
demonstrating the predominant localization of NaPi-IIa in the BBM.
At 5–15 min after 1-34 PTH injection, the intensity of NaPi-IIa-related
staining was decreased in the BBM (orange appearance) and a large
green fluorescent rim appears below the BBM. Thirty minutes after
PTH injection, the intensity of the intracellular NaPi-IIa staining
(green) below the subapical region is increased. After 60 min,
intracellular NaPi-IIa staining has disappeared and BBM was colored
in red. Bar¼B10 mm.
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related immunostaining appeared in the subapical compart-
ments and the intensity of the yellow staining fainted and
shifted toward red, indicating that the downregulatory effect
of PTH on NaPi-IIa expression in the brush border. These
observations are in agreement with previous data by us and
others.10,14
Localization of NaPi-IIa in endocytotic compartments after
PTH treatment
In order to identify the internalization route of NaPi-IIa to
the lysosomes, we used antibodies against defined markers of
several intracellular compartments known to be involved in
the endocytic removal of membrane proteins (Figure 3).
Shortly after PTH injection, NaPi-IIa staining (green label)
moved to a subapical compartment, and started to colocalize
with staining for clathrin (red label) below the brush
border, indicating that the first steps in retrieval may
involve clathrin-coated pits (Figure 3, after 5–15 min of
PTH injection). Between 15 and 30 min after PTH treatment,
colocalization of NaPi-IIa with clathrin became weaker,
whereas vesicles labeled for NaPi-IIa showed frequently
colocalization with the early endosomal antigen 1 (EEA1)
(Figure 3, 15–30 min). To test whether internalized type IIa
Na/Pi cotransporters under in vivo conditions are directed to
the lysosomes, rats were treated with leupeptin to block
lysosomal degradation before the treatment with PTH for
60 min. The distribution pattern of NaPi-IIa in the proximal
tubule of control animals after leupeptin injection alone was
in all respects identical to control animals that were not
injected with leupeptin (data not shown). At 60 min after
PTH injection, a strong overlap of internalized type IIa
cotransporters with the late endosome/lysosome marker
lgp120 was observed. In cortex sections obtained from rats
infused with PTH but not pretreated with leupeptin,
intracellular NaPi-IIa-related staining was found to be weaker
(Figure 2, after 60 min of PTH injection), but still clearly
present in late endosomes and lysosomes.
Distribution of NHE3 in kidneys of rats treated with PTH
To determine whether localization of the BBM-expressed
Naþ /Hþ exchanger NHE3 changes after acute treatment
with PTH, dual labeling of NHE3 (green label) and b-actin
(red label) was performed on cryosections from control and
PTH-treated kidneys (Figure 4). Two different antibodies
against NHE318,19 provided identical results. These results
suggest that NHE3 is retracted to a domain at the base of the
microvilli above the clathrin-coated vesicles in response to
PTH treatment, but it does not move deeper in the cell. Our
findings confirm a previous study by Yang et al.20
Effect of PTH on megalin localization in rat kidneys
We have previously shown that megalin, part of the receptor-
mediated endocytic pathway (for review, see Christensen and
Birn11,12 and Willnow et al.21), may play an important role in
the PTH-induced internalization of the NaPi-IIa.14,15 There-
fore, we examined the localization of megalin after PTH
treatment. It has already been shown that in the BBM, NaPi-
IIa and megalin colocalize but during the PTH-induced
internalization these two proteins do not share the same fate.
After PTH injection, megalin (green label) was not detected
by immunohistochemistry in clathrin- or EEA1-positive
compartments (red label). Slight overlap (orange) of megalin
and clathrin was found, due to localization of megalin in the
deep invaginations of the BBM, where clathrin-coated pits
are formed. There was no clear difference in the localization
of megalin between untreated and PTH-treated animals
(Figure 5).
Endocytosis of NaPi-IIa follows the receptor-mediated
endocytic pathway
Two major routes of protein internalization from the apical
membrane in the renal proximal tubule have been described:
the receptor-mediated and the fluid-phase endocytic
routes.11,12 In order to identify the route of NaPi-IIa
internalization, we used insulin and HRP as markers of the
receptor-mediated and fluid-phase routes, respectively. In a
first series of experiments, we found strong labeling of
reabsorbed endogenous insulin in the proximal tubule.
Therefore, rats were fasted for 18 h before the experiments
in order to lower endogenous plasma levels of insulin to
be able to detect the exogenously administered insulin
(Figure 6). The localization of NaPi-IIa was not affected
by the injection of insulin over a period of 5–30 min (data
not shown). Animals were coinjected with PTH and insulin
for different time points. Dual labeling of NaPi-IIa (green
label) and insulin (red label) showed a strong overlap of these
two proteins in endocytic compartments (granular orange-
yellow staining), indicating that NaPi-IIa may have been
endocytosed via receptor-mediated endocytosis (Figure 7 and
Figure 10). Kidney sections from rats injected with the fluid-
phase endocytic markers HRP or fluorescein isothiocyanate
(FITC)-dextran (7 kDa) coinjected with PTH were double-
labeled with NaPi-IIa (green label) and HRP or FITC-dextran
(red label). HRP or FITC-dextran injection alone had
no influence on the pattern of NaPi-IIa staining pattern
(data not shown). The results demonstrated retrieval of
NaPi-IIa from the BBM, but NaPi-IIa-related staining did
only weakly overlap with HRP-labeled or FITC-dextran-
containing endosomes (Figures 8–10). A direct comparison at
higher magnification of NaPi-IIa with insulin- and HRP-
labeled compartments showed a high degree of colocalization
of NaPi-IIa with insulin but not HRP-containing vesicles
(Figure 10).
DISCUSSION
In the present study, we traced the internalization pathway of
the Naþ /phosphate cotransporter NaPi-IIa in proximal
tubular cells in vivo using immunofluorescence microscopy
and employing specific markers of different endocytic
pathways and compartments. The high degree of overlap of
NaPi-IIa with endocytosed insulin indicates that NaPi-IIa is
removed from the BBM by receptor-mediated endocytosis.
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This is corroborated by the previously demonstrated
importance of the endocytic receptor megalin. Indeed, the
acute internalization of NaPi-IIa in response to PTH was
delayed in mice deficient for RAP, a chaperone of megalin, or
in mice with a kidney-specific reduction in megalin
expression.14,15 However, the experiments did not allow to
distinguish between a direct participation of megalin in
NaPi-IIa internalization and a more general disruption of the
Control
Merge Clathrin NaPi-lla Merge EEA1 NaPi-lla
Merge lgp 120 NaPi-lla
PTH 5 min
PTH 15 min
PTH 30 min
PTH 60 min
Control
PTH 5 min
PTH 15 min
PTH 30 min
PTH 60 min
a
b
Figure 3 | Colocalization of NaPi-IIa (green label) with clathrin, EEA1, and the lysosomal marker lgp120 (red label); cryostat sections,
immunofluorescence. (a,b) All pictures were taken from the S1 segments of superficial nephrons. At 5 and 15 min after PTH application,
vesicles were colabeled for NaPi-IIa and clathrin (orange/yellow). Thirty minutes after treatment of animals with PTH, NaPi-IIa molecules were
detected in deeper subapical regions and an overlap of internalized type II cotransporters with EEA1 was observed (orange/yellow). In sections
of kidneys where 45 min after leupeptin injection PTH was administrated for 60 min, NaPi-IIa-related immunoflourescence was absent from the
BBM and subapical compartment. Intracellular NaPi-IIa-related staining increased and to a large extent overlapped with the distribution pattern
of the late endosome/lysosome marker lgp120 (orange/yellow). Bar¼B15 mm.
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apical endocytic apparatus due to loss of megalin. Megalin
serves as a receptor for the endocytosis of multiple ligands in
the proximal tubule.11,12,14,15 Reduction or loss of megalin
expression and function is associated in mouse models and
patients (Fanconi type syndromes) with urinary loss of
vitamin D3, albumin, and other smaller proteins resulting in
the disturbance of whole body calcium homeostasis and bone
development.22–24 In addition to its role in endocytosis of
proteins from the urine, it has been suggested that megalin
may directly interact with proteins in the BBM such as the
Naþ /Hþ exchanger NHE3 and may be important for the
regulation and expression of this protein by mediating its
endocytosis and membrane recycling.25 In the BBM, NaPi-IIa
and megalin colocalize,14,15 but during the PTH-induced
internalization these two proteins do not share the same fate.
Megalin is recycled back to the membrane via dense apical
tubules,12 whereas NaPi-IIa is degraded in the lysosomes.6–9
As, after injection of PTH, megalin could not be detected in
clathrin- or EEA1-positive compartments, potential inter-
actions between megalin and NaPi-IIa may have occurred at
an earlier time point during internalization. It is noteworthy
that there is no evidence yet for a direct protein–protein
interaction of NaPi-IIa and megalin (Gisler, Biber, Murer,
unpublished results).
Whereas the results presented above indicate that the
receptor-mediated endocytosis is involved in the rapid
internalization of NaPi-IIa in response to PTH, no evidence
was found for an involvement of the fluid-phase endocytic
pathway. Indeed, HRP or FITC-dextran and NaPi-IIa did not
show any significant overlay at any time point investigated.
This is in contrast to a previous report suggesting that NaPi-
IIa may be internalized via an HRP-accumulating compart-
ment.6 These findings had been based on indirect immuno-
fluoresence and immuno-gold labeling. In view of the low
grade of overlap between FITC-dextran or HRP with NaPi-
IIa found here, these earlier findings may be explained either
by a low amount of NaPi-IIa being internalized also via
the fluid-phase-dependent endocytic pathway (which cannot
be detected by indirect immunofluorescence) or by an
unspecific binding of antibodies during immuno-gold
detection.
The receptor-mediated endocytic pathway involves cla-
thrin-coated vesicles, which fuse with the cisterns and
tubes (‘early endosomes’) of the vacuolar apparatus, situated
in the subapical compartment. From there, both insulin
and NaPi-IIa were targeted via large endocytotic vacuoles
(‘late endosomes’) into lysosomes. The involvement of
clathrin is supported by previous studies on OK opossum
kidney cells showing a reduced rate of endocytosis of
NaPi-IIa by high medium osmolarity, the condition under
which the endocytic mechanism is impaired.26 Clathrin-
mediated endocytosis plays an important role in regulating
the membrane expression of other transport systems,
for example, the vasopressin-dependent water channel
aquaporin-2 in collecting duct principal cells and LLC-PK1
cells.27,28
We were unable to observe an acute internalization of
NHE-3 from the BBM in the rat model presented in this
study. These results confirmed previous observations from
our lab in mice and rats14,15 (unpublished data) and from a
recent publication by Yang et al.,20 where clear evidence was
provided for the PTH-induced retrieval of NHE3 from the
top of the brush border microvilli to the intermicrovillar cleft
region, but not its internalization. However, we cannot
exclude that a small number of NHE3 exchangers was
internalized but could not be detected by our methods.
In summary, we provide evidence that NaPi-IIa is
internalized after acute application of PTH using a pathway
overlapping with markers of the receptor-mediated endo-
cytosis, but not fluid-phase endocytosis. This endocytic route
includes clathrin-coated vesicles and early and late endo-
somes, and traffics NaPi-IIa to lysosomes for degradation.
Previous evidence supports these data demonstrating the
critical role of an intact apical apparatus for receptor-
mediated endocytosis.
Control
Red: -Actin
Green: 1568 NHE3 mNHE3
PTH 5 min
PTH 15 min
PTH 30 min
PTH 60 min
Figure 4 | Effect of acute PTH application on NHE3 distribution;
cryostat sections, immunofluorescence. Rats were injected with
PTH and kidneys fixed after 5, 15, 30, or 60 min. No difference in
NHE3-related staining was detected between untreated control
rats and rats injected with 1-34 PTH. Two different antibodies
against NHE3 were used: a rabbit polyclonal antibody that recognizes
NHE3 mainly at the bottom and deep invaginations of the BBM
(upper panel) and a monoclonal anti-NHE3 antibody that stains
NHE3 along the whole length of the BBM (lower panel). Under
all conditions, distribution of NHE3 in the BBM appeared
unchanged. NHE3 is stained in green and b-actin filaments in
red. Bar¼B10mm.
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MATERIALS AND METHODS
Animals
All animal studies were according to Swiss Animal Welfare
laws and approved by the local Cantonal Veterinary
Authority of Zurich. The experiments were performed with
male Wistar rats (120–150 g). The rats were kept on a low-
phosphate diet (0.1% Pi content) (Kliba AG, Switzerland) for
3 days to upregulate NaPi-IIa in the BBM of all proximal
tubular segments as described previously.17 In one group of
animals used to stain for insulin, 18 h before PTH, HRP, or
insulin injections, the food was removed in order to lower the
animals’ serum level of endogenous insulin.
A total of 53 rats were used divided into four separate
experiments: experiment 1: injection of PTH after applica-
tion of leupeptine; experiment 2: injection of PTH and
insulin; experiment 3: injection of PTH and HRP; and
experiment 4: injection of PTH and FITC-dextran.
Rats were anesthetized with thiopental (Pentothal,
100 mg/kg body weight) injected intraperitoneally, their
abdominal cavity was opened, and the aorta and vena cava
were exposed. All animals received either saline as control or
PTH (PTH 1-34 fragment, 10 mg/100 g body weight (Sigma,
St Louis, MO, USA)) injections as a bolus into the vena cava
or the tail vein. The rats were perfused at each time point and
fixed by perfusion.
Four separate experiments were performed and each
experiment consisted of five groups with three animals per
group.
Experiment 1: injection of PTH and leupeptin. Group 1
remained untreated and served as control animals. Groups 2
and 3 were injected with 1-34 PTH for 5/15 min before
fixation as a single bolus injected into the vena cava. Groups
4 and 5 were injected into the tail vena as a single bolus with
1-34 PTH for 30/60 min before fixation. Additionally, group
5 received 6 mg leupeptin (Sigma) dissolved in 0.5 ml
phosphate-buffered saline (PBS) as an injection into the tail
vena before the PTH injection (into the tail vena as a single
bolus).
Experiment 2: injection of PTH and insulin. Group 1
remained untreated and served as control animals. Group 2
was injected for 5 min with 1 U human insulin (Sigma) into
the vena cava before fixation. Groups 3 and 4 were coinjected
with 1-34 PTH and 1 U human insulin (Sigma) 5/15 min
before fixation (as a single bolus injected into the vena
cava). Group 5 was injected with 1-34 PTH into the tail
vena. Fifteen minutes after PTH injection, 1 U human insulin
(Sigma) was injected into the vena cava as a single bolus and
animals fixed by perfusion after 15 min.
Experiment 3: injection of PTH and HRP. Group 1 remained
untreated and served as control animals. Group 2 was
injected with 0.75 ml of HRP-PBS solution (25 mg HRP,
Control
Merge Clathrin Megalin MegalinMerge EEA1
PTH 5 min
PTH 15 min
PTH 30 min
Figure 5 | Localization of megalin (green label), clathrin (red label), and EEA1 (red label) in S1 segments of superficial nephrons from
control rats and rats injected with PTH; cryostat sections, immunofluorescence. Megalin is abundant and seen throughout the entire
length of the BBM, clathrin is found below the brush border, and EEA1 slightly deeper in the cells. No difference was seen for megalin staining
between control and treated animals. Bar¼B10mm.
a b c
Figure 6 | Localization of insulin in S1 proximal tubular cells;
cryostat sections, immunofluorescence. (a) Normally fed rats,
(b) rats starved for 18 h, and (c) rats that were starved for 18 h and
injected with insulin 5 min before perfusion fixation. Endogenous
insulin was abundant in S1 proximal tubular cells in normally fed
animals but not detected in starved animals. Insulin injected in
starved rats was readily detected in subapical vesicles. Bar¼B50 mm.
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Sigma type II, dissolved in 0.75 ml PBS; Sigma) into the vena
cava 5 min before fixation. Groups 3 and 4 were coinjected
with 1-34 PTH and HRP (as a single bolus injected into the
vena cava) 5/15 min before fixation. Group 5 was injected
with 1-34 PTH into the tail vena 30 min before fixation.
Fifteen minutes after the PTH injection, HRP was injected
into the vena cava as a single bolus.
Experiment 4: injection of PTH and FITC-dextran. Group 1
remained untreated and served as control animals. Group 2
was injected with 0.75 ml of FITC-dextran (10 kDa) solu-
tion (1.75 mg/100 g body weight, dissolved in 0.75 ml
0.9% NaCl; Molecular Probes, Eugene, OR) into the vena
cava 5 min before fixation. Groups 3 and 4 were coinjected
with 1-34 PTH and FITC-dextran (as a single bolus injected
into the vena cava) 5/15 min before fixation. Group 5
was injected with 1-34 PTH into the tail vena 30 min
before fixation. Fifteen minutes after the PTH injection,
FITC-dextran was injected into the vena cava as a single
bolus.
After treatment, all animals were fixed by vascular
perfusion via the abdominal aorta, at a pressure of 0.4 bar,
as described previously.29 The fixative consisted of 3%
paraformaldehyde, 0.1% glutaraldehyde, and 0.05% picric
acid in 0.6 M cacodylate buffer (pH 7.4; containing 3 mM
MgCl2 and adjusted to 300 mosmol/l with sucrose) and 4%
hydroxyethyl starch in saline (HAES steril; Fresenius, Stans,
Switzerland). After 5 min, the fixative was washed out by
perfusion with hydrostatic pressure of 70 cm for 5 min with
Control
NaPi-lla Insulin Overlay
PTH 5 min
PTH 15 min
PTH 30 min
Figure 7 | Double staining for NaPi-IIa (green label) and insulin
(red label); cryostat sections, immunofluorescence. After coinjec-
tion of PTH and insulin, distribution of NaPi-IIa during PTH treatment
is similar to that of insulin. Intracellular NaPi-IIa and insulin overlap
(orange/yellow) to a large extent. Bar¼B15 mm.
Control
NaPi-lla HRP Overlay
PTH 5 min
PTH 15 min
PTH 30 min
Figure 8 | Double staining for NaPi-IIa (green label) and HRP (red
label) in rats injected with PTH and HRP; cryostat sections,
immunofluorescence. NaPi-IIa-containing endocytic compartments
do not overlap with HRP-labeled compartments. Bar¼B15mm.
Control
NaPi-lla FITC-dextran Overlay
PTH 5 min
PTH 15 min
PTH 30 min
Figure 9 | Double staining for NaPi-IIa (green label) and FITC-
dextran (red label) in rats injected with PTH and FITC-dextran;
cryostat sections, immunofluorescence. NaPi-IIa-containing endo-
cytic compartments do not overlap with FITC-dextran-labeled
compartments. Bar¼B15mm.
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cacodylate buffer. Kidneys were removed and subsequently
used for analysis by immunohistochemistry.
Immunohistochemistry
Slices of fixed kidneys were frozen in liquid propane and
cooled with liquid nitrogen. Sections, 3 mm thick, were cut at
221C on a cryomicrotome, mounted on chromalum/
gelatine-coated glass slides, thawed, and kept in cold PBS
until use. Before immunofluorescence staining, sections were
washed three times for 10 min with 50 mM NH4Cl in PBS and
then pretreated with blocking solution (PBS with 0.1%
bovine serum albumin containing 0.02% Triton X-100) for
10 min. After blocking, sections were washed three times in
PBS and incubated overnight at 41C with a rabbit anti-rat
antiserum against the NaPi-IIa protein30 diluted 1:1000, with
a rabbit anti-megalin antiserum (kind gift of Dr Ziak and Dr
Roth, Institute of Pathology, University of Zurich) diluted
1:10 000, with a rabbit anti-rat NHE3 antiserum (kindly
provided by Dr Orson W Moe, University of Texas South-
western Medical Center, Dallas, TX, USA) at a dilution of
1:1000, or with a mouse anti-rabbit NHE3 monoclonal
antibody (clone 2B9; Chemicon International, Temecula, CA)
diluted 1:50. All primary antibodies were diluted in blocking
solution and incubated overnight at 41C. For double staining,
the following mouse monoclonal antibodies were diluted in a
PBS/bovine serum albumin solution containing the NaPi-IIa
antiserum: anti-HRP (Sigma) (1:250); anti-EEA1 (BD
Transduction Lab, Pharmingen, Franklin Lakes, NJ, USA)
and anti-clathrin (BD Transduction Lab) (both 1:100); and
anti-lgp 120 antibody (kindly provided by Dr I Melman, Yale
University) and anti-insulin (Sigma) (both 1:50). Sections
were then rinsed three times with PBS and covered for 45 min
at 41C with the secondary antibodies. Swine anti-rabbit IgG
conjugated to FITC (Dakopatts, Glostrup, Denmark) was
diluted 1:50 and goat anti-mouse IgG conjugated to Cy3
(Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) was diluted 1:500, both in PBS/3% milk powder.
Double stainings of NaPi-IIa or NHE3 with b-actin filaments
were achieved by adding rhodamine-phalloidin (Molecular
Probes), at a dilution of 1:50 in the solution containing
FITC-labeled secondary antibodies. Finally, the sections were
rinsed three times with PBS, coverslipped using DAKO-
Glycergel (Dakopatts) containing 2.5% 1,4-diazabicy-
clo[2.2.2]octane (Sigma) as a fading retardant, and studied
either on an epifluorescence microscope (Polyvar, Reichert-
Control
Green: NaPi-lla
Red: Insulin
Green: NaPi-lla
Red: HRP
PTH 5 min PTH 15 min PTH 30 min
Figure 10 | Double staining for NaPi-IIa and insulin (upper panel)
and NaPi-IIa and HRP (lower panel) in control and PTH-treated
rats; cryostat sections, immunofluorescence. Distribution of
endocytosed NaPi-IIa (green label) shows a high degree of overlap
with insulin (red label) (overlap appears in orange-yellow) that is
endocytosed via the receptor-mediated endocytotic pathway;
compartments labeled with HRP (red label), representing the
fluid-phase endocytotic pathway, do not overlap with endocytosed
NaPi-IIa. Bar¼B15 mm.
Group Treatment
Delay between PTH injection
and fixation (min) n
1 Untreated — 3
2 1-34 PTH 5 3
3 1-34 PTH 15 3
4 1-34 PTH 30 3
5 Leupeptin
45 min+1-34 PTH
60 3
PTH: parathyroid hormone.
Group Treatment
Delay between insulin injection
and fixation (min) n
1 Untreated — 3
2 Insulin 5 3
3 1-34 PTH+insulin 5 3
4 1-34 PTH+insulin 15 3
5 1-34 PTH
30 min+insulin
15 3
PTH: parathyroid hormone.
Group Treatment
Delay between HRP
injection and fixation (min) n
1 Untreated — 3
2 HRP/PBS 5 3
3 1-34 PTH+HRP 5 3
4 1-34 PTH+HRP 15 3
5 1-34 PTH 30 min+HRP 15 3
HRP: horseradish peroxidase; PBS: phosphate-buffered saline; PTH: parathyroid
hormone.
Group Treatment
Delay between HRP
injection and fixation (min) n
1 Untreated — 2
2 FITC-dextran/PBS 5 3
3 1-34 PTH+FITC-dextran 5 3
4 1-34 PTH+FITC-dextran 15 3
5 1-34 PTH 30 min+FITC-dextran 15 3
HRP: horseradish peroxidase; FITC: fluorescein isothiocyanate; PBS: phosphate-
buffered saline; PTH: parathyroid hormone.
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Jung, Austria) or on a confocal microscope (Leica SP1 UV
CLSM).
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